TAMSULOSINE VIATRIS L.P. 0.4 mg, extended-release capsule 30 capsules, CIP 3400937057356
Active ingredients: Tamsulosin hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule30 capsules, CIP 3400937057356orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAMSULOSINE VIATRIS L.P. 0,4 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 gélule(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 25 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68840153CIP73705735CIP133400937057356Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TAMSULOSINEgélule | 0,4 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.